TG Therapeutics TGTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 33.22 | 124.14 | 11.86 | 0.12 | 34,795 | 20 |
| 2025Q4 | 29.81 | 97.81 | 10.58 | 0.15 | 50,494 | 23 |
| 2025Q3 | 36.13 | 89.99 | 94.81 | 2.43 | 29,365 | 391 |
| 2025Q2 | 35.99 | 92.58 | 145.94 | 0.17 | 34,843 | 28 |
| 2025Q1 | 39.43 | 70.53 | 264.86 | 0.03 | 8,622 | 5 |
| 2024Q4 | 30.1 | 92.11 | 0.15 | 29,949 | 23 | |
| 2024Q3 | 23.39 | 83.06 | 37.85 | 0.03 | 12,434 | 4 |
| 2024Q2 | 17.79 | 83.74 | 66.74 | 0.04 | 8,816 | 7 |
| 2024Q1 | 15.21 | 110.49 | 185.35 | -0.07 | -9,270 | -11 |
| 2023Q4 | 17.08 | 107.68 | -0.1 | -12,485 | -14 | |
| 2023Q3 | 8.36 | 97.57 | 0.81 | 114,783 | 114 | |
| 2023Q2 | 24.84 | 101.57 | -0.34 | -44,673 | -48 | |
| 2023Q1 | 15.04 | 101.66 | -0.28 | -36,992 | -39 | |
| 2022Q4 | 11.83 | 103.85 | -0.57 | -52,062 | -53 | |
| 2022Q3 | 5.92 | 102.32 | -0.27 | -34,964 | -36 | |
| 2022Q2 | 4.25 | 103.86 | -0.3 | -38,941 | -41 | |
| 2022Q1 | 9.51 | 100.79 | -0.51 | -66,872 | -69 | |
| 2021Q4 | 19 | 100.75 | -0.7 | -92,947 | -93 | |
| 2021Q3 | 33.28 | 100.63 | -0.65 | -85,129 | -86 | |
| 2021Q2 | 38.79 | 100.8 | -0.59 | -77,492 | -78 |